Theodore R. Schroeder, Chief Executive Officer at Nabriva Therapeutics plc (NBRV), bought 200,000 shares at $0.57 ($114K) on 2021-12-28, disclosed to the SEC on 2021-12-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.57 | 100,000 | $57K | 50.0% |
| 2 | $0.57 | 100,000 | $57K | 50.0% |
| Total | $0.57 avg | 200,000 | $114K | 100% |
| Filing → |
| CADX | BUY | 2011-05-17 | $120K | — | Filing → |
| CADX | SELL | 2010-10-04 | $418K | — | Filing → |
| CADX | SELL | 2010-07-01 | $350K | — | Filing → |